1. Home
  2. GRC vs KLRA Comparison

GRC vs KLRA Comparison

Compare GRC & KLRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gorman-Rupp Company (The)

GRC

Gorman-Rupp Company (The)

HOLD

Current Price

$71.07

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo Kailera Therapeutics Inc. Common Stock

KLRA

Kailera Therapeutics Inc. Common Stock

N/A

Current Price

$13.61

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GRC
KLRA
Founded
1933
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
1994
2026

Fundamental Metrics

Financial Performance
Metric
GRC
KLRA
Price
$71.07
$13.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
110.4K
808.7K
Earning Date
04-23-2026
N/A
Dividend Yield
1.04%
N/A
EPS Growth
32.03
N/A
EPS
1.41
N/A
Revenue
$682,389,000.00
N/A
Revenue This Year
$6.62
N/A
Revenue Next Year
$4.66
N/A
P/E Ratio
$52.82
N/A
Revenue Growth
3.44
N/A
52 Week Low
$42.31
$13.90
52 Week High
$92.78
$23.82

Technical Indicators

Market Signals
Indicator
GRC
KLRA
Relative Strength Index (RSI) 30.78 33.33
Support Level $68.94 N/A
Resistance Level $73.24 $19.02
Average True Range (ATR) 2.02 1.22
MACD -0.25 -0.23
Stochastic Oscillator 1.92 3.42

Price Performance

Historical Comparison
GRC
KLRA

About GRC Gorman-Rupp Company (The)

Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of its revenue from the United States.

About KLRA Kailera Therapeutics Inc. Common Stock

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

Share on Social Networks: